Opus Medical

Opus Medical

Motion management devices for radiation therapy

Overview

Opus Medical designs, manufactures, and distributes motion management devices for radiation therapy and medical imaging to keep patients still during treatments and scans. Its immobilization and positioning tools minimize movement, improving the accuracy of radiation delivery and the clarity of diagnostic images. The company differentiates itself through its academic roots from Stanford University and the University of Sydney, local Australian manufacturing in Cicada Innovations, and an evidence-based approach to product development and support. Its goal is to expand access to reliable motion management solutions for oncology and radiology worldwide, reducing patient risk and improving diagnostic quality.

About Opus Medical

Simplify's Rating
Why Opus Medical is rated
D+
Rated C on Competitive Edge
Rated D+ on Growth Potential
Rated D+ on Differentiation

Industries

Industrial & Manufacturing

Healthcare

Company Size

1-10

Company Stage

Series C

Total Funding

$22.2M

Headquarters

Belgium

Founded

1999

Get referred to Opus Medical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Dynamic Business reported active sales and dozens of patients using Breathe Well in 2026.
  • FDA, CE, and TGA approvals open hospitals in Australia, Europe, and America.
  • University of Sydney disclosures confirm licensed biofeedback patents and founder ownership.

What critics are saying

  • PitchBook labeled Opus Medical Out of Business in 2025, contradicting 2026 marketing.
  • The website name now points to a Texas case-management firm, signaling brand or corporate collapse.
  • Without scale beyond Breathe Well, Medtronic, Varian, and Elekta can absorb the niche by 2027.

What makes Opus Medical unique

  • Breathe Well, born from Stanford and Sydney research, targets radiation breath-hold precision.
  • Paul Keall and Sean Pollock anchor the clinical-scientific credibility around 2014.
  • Local Sydney manufacturing supports device control, regulatory compliance, and clinical customization.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$22.2M

Below

Industry Average

Funded Over

3 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Below Average

Industry standards

$50M
$13.6M
Opus Medical
$40M
Figma
$50M
Medium
$62M
SeatGeek
$100M
Oura

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Nurse Referral Bonus

Professional Development Budget

Performance Bonus

Recently Posted Jobs

Sign up to get curated job recommendations

Opus Medical is Hiring for 13 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →